Pyxis Oncology's market cap is currently ―. The company's EPS TTM is $-1.864; its P/E ratio is -2.59; Pyxis Oncology is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 562.00K	$ 600.00K	$ 600.00K	$ 38.00K	-
Gross Profit	$ 562.00K	$ 600.00K	$ 600.00K	$ 38.00K	-
EBIT	$ -15.44M	$ -23.07M	$ -16.65M	$ -18.55M	$ -37.97M
EBITDA	$ -16.19M	$ -24.02M	$ -17.38M	$ -18.96M	$ -37.79M
Net Income Common Stockholders	$ -16.27M	$ -23.07M	$ -15.90M	$ -18.55M	$ -36.10M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 119.30M	$ 132.97M	$ 144.13M	$ 150.82M	$ 180.77M
Total Assets	$ 173.73M	$ 186.69M	$ 175.23M	$ 182.80M	$ 211.38M
Total Debt	$ 21.33M	$ 21.62M	$ 21.26M	$ 20.25M	$ 18.92M
Net Debt	$ -97.97M	$ -111.35M	$ -122.88M	$ -130.57M	$ -161.85M
Total Liabilities	$ 48.02M	$ 48.75M	$ 29.95M	$ 30.64M	$ 50.55M
Stockholders Equity	$ 125.70M	$ 137.95M	$ 145.28M	$ 152.16M	$ 160.82M
Cash Flow	-
Free Cash Flow	$ -15.25M	$ -17.64M	$ -13.29M	$ -31.25M	$ -19.25M
Operating Cash Flow	$ -15.25M	$ -17.58M	$ -11.03M	$ -26.84M	$ -17.39M
Investing Cash Flow	$ 10.23M	$ 6.57M	$ -22.25M	$ -99.39M	$ -1.86M
Financing Cash Flow	$ -25.00K	$ -171.00K	$ 6.13M	-	-

Currency in USD

Pyxis Oncology Earnings and Revenue History

Income Statement >

Pyxis Oncology Debt to Assets

Balance Sheet >

Pyxis Oncology Cash Flow

Cash Flow >

Pyxis Oncology Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing